Combined ASBT inhibitor and FGF15 treatment improves therapeutic efficacy in experimental non-alcoholic steatohepatitis

Title
Combined ASBT inhibitor and FGF15 treatment improves therapeutic efficacy in experimental non-alcoholic steatohepatitis
Authors
Keywords
Bile Acids, Fatty Liver, CYP7A1, NASH, Liver Fibrosis
Publisher
Elsevier BV
Online
2021-05-07
DOI
10.1016/j.jcmgh.2021.04.013

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started